Metabolic Disorders
From Proteopedia
(Difference between revisions)
| Line 25: | Line 25: | ||
*[[: Category:Metabolic disorder|Metabolic Disorder]] | *[[: Category:Metabolic disorder|Metabolic Disorder]] | ||
<br /> | <br /> | ||
| + | |||
| + | To View FDA Approved Treatments for [[Metabolic Disorders]] See: [[Pharmaceutical_Drugs#Treatments|Treatments]] | ||
To view other Proteopedia pages about diseases & drug targets, See: [[Pharmaceutical_Drug_Targets|Pharmaceutical Drug Targets]] | To view other Proteopedia pages about diseases & drug targets, See: [[Pharmaceutical_Drug_Targets|Pharmaceutical Drug Targets]] | ||
Revision as of 11:45, 29 November 2010
Metabolic Disorders broadly covers illnesses related to faulty carbohydrate metabolism, amino acid metabolism, organic acid metabolism, or lysosomal storage.
Articles in Proteopedia concerning Metabolic Disorders include:
- Acid-beta-glucosidase
- ß-2 Microglobulin
- HMG-CoA Reductase
- Protective Protein/Cathepsin A (PPCA)
- Protective Protein/Cathepsin A (PPCA) 2
- Thiolase
- Treatment of Gaucher Disease
- Velaglucerase
- Velaglucerase Disulfide Connectivity
To view proteins related to Metabolic Disorders which are Structure Index entries see:
To view automatically seeded indices concerning Metabolic Disorders See:
To View FDA Approved Treatments for Metabolic Disorders See: Treatments
To view other Proteopedia pages about diseases & drug targets, See: Pharmaceutical Drug Targets
